Supreme Petrochem Ltd
Supreme Petrochem Ltd
CommoditiesKey Fundamentals
MicrocapPetrochemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Supreme Petrochem Ltd insights
42 extracted metrics + investor summaries across FY16–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 52.4%
Weaknesses
1- The company has delivered a poor sales growth of 10.9% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Supreme Petrochem Ltd trades at a market cap of ₹13,483 Cr with a P/E of 27.8x and P/B of 5.68x. The company is virtually debt-free and maintains a 52.4% dividend payout, but faces headwinds from stagnant sales growth (0% CAGR over 3 years) despite a recent 40% TTM profit jump.
- Company is almost debt-free, giving it financial flexibility and resilience during commodity downturns
- Healthy dividend payout ratio of 52.4% signals shareholder-friendly capital allocation and consistent cash generation
- TTM profit growth of 40% indicates a strong recent recovery in margins and profitability
- 10-year compounded profit growth of 19% demonstrates long-term earnings compounding ability
- 10-year stock CAGR of 23% reflects sustained long-term wealth creation for shareholders
- 5-year stock CAGR of 16% shows above-average medium-term price appreciation
- Dividend yield of 1.47% provides a meaningful income component relative to commodity sector peers
- 10-year ROE average of 24% indicates historically efficient use of shareholder equity
- 3-year compounded sales growth is flat at 0%, indicating no top-line expansion over medium term
- TTM sales growth is negative at -3%, showing current revenue contraction
- 3-year compounded profit decline of -12% suggests recent earnings volatility despite TTM recovery
- P/E of 27.8x is elevated for a commodity-chemicals company with stagnant revenue growth
- P/B of 5.68x is high, implying the market prices in significant future growth that may not materialize given flat sales
- ROE has declined from 24% (10-year average) to 14% last year, signaling deteriorating return efficiency
- 5-year compounded profit growth is negative at -7%, indicating earnings have shrunk over a half-decade horizon
- 1-year stock return of -1% shows the market has stalled on the stock amid growth concerns
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Margin normalization expected ahead Jul 30
Current 19.53% EBITDA margin described as an aberration driven by favorable styrene monomer-to-downstream deltas; management expects normalization over time.
- No FY27 volume guidance given Jul 30
Management refrained from issuing FY2027 volume guidance citing uncertainty around exports, styrene availability, shipping space, and freight rates due to fluid West Asia situation.
- Q1 net profit surges 192% YoY Jul 27
Standalone net profit jumped ~192% YoY to ₹23,633.43 lakh in Q1FY27; revenue from operations rose to ₹1,69,270.78 lakh.
- INR900 Cr CapEx for expansion Jul 30
Total estimated CapEx of INR900 crores announced for multiple projects including compounding capacity growth from 50,000 to 80,000 TPA by June 2027 and a new 80,000 TPA polystyrene line at Amdoshi Complex by December 2028, lifting total PS capacity to 380,000 TPA.
- Expansion funded internally Jul 30
All expansion projects to be funded through internal accruals with completion targeted by March 2029, avoiding equity dilution or debt burden.
- Independent ESG rating received Aug 11
NSE Sustainability Ratings & Analytics independently assigned an ESG rating to Supreme Petrochem without the company engaging the agency.
- Investor meetings scheduled Aug 2
In-person investor meetings scheduled with ASK Mutual Fund on Aug 6 and Takshil Financial Services on Aug 11, 2026, per SEBI disclosure norms.
- Q1 FY27 earnings call published Jul 29
Audio recording of the Q1 FY27 earnings conference call held on July 29, 2026 made available on the company website.
TL;DR: Supreme Petrochem delivered a standout Q1FY27 with 192% YoY profit growth and announced an ambitious INR900 Cr internally-funded capacity expansion plan. Key risks include expected margin normalization from current elevated levels and management's reluctance to guide on FY27 volumes due to West Asia-related supply chain uncertainties. The near-term trend is strong on earnings momentum, but investors should watch for margin compression as styrene spreads revert to normal.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 | 1,405 | 1,539 | 1,387 | 1,100 | 1,265 | 1,587 | 1,693 |
| Expenses | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 | 1,306 | 1,394 | 1,272 | 1,023 | 1,195 | 1,334 | 1,362 |
| Operating Profit | 90 | 106 | 95 | 175 | 161 | 125 | 99 | 145 | 115 | 78 | 69 | 253 | 331 |
| OPM % | 7% | 8% | 8% | 11% | 10% | 8% | 7% | 9% | 8% | 7% | 5% | 16% | 20% |
| Other Income | 18 | 16 | 16 | 19 | 23 | 17 | 17 | 19 | 15 | 9 | 2 | 8 | 17 |
| Interest | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 |
| Depreciation | 14 | 14 | 15 | 16 | 16 | 17 | 17 | 17 | 18 | 18 | 27 | 28 | 28 |
| PBT | 94 | 106 | 92 | 177 | 164 | 122 | 96 | 143 | 109 | 65 | 40 | 229 | 317 |
| Tax % | 26% | 26% | 27% | 26% | 26% | 26% | 26% | 25% | 25% | 26% | 25% | 27% | 25% |
| Net Profit | 69 | 78 | 68 | 132 | 122 | 90 | 71 | 107 | 81 | 48 | 30 | 168 | 236 |
| EPS in Rs | 3.68 | 4.15 | 3.6 | 6.99 | 6.49 | 4.8 | 3.79 | 5.68 | 4.3 | 2.56 | 1.6 | 8.94 | 12.57 |
Profit & Loss
| Jun 2015 | Mar 2016 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 6,023 | 5,338 | 5,645 |
| Expenses | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,511 | 4,126 | 4,626 | 4,780 | 5,488 | 4,820 | 4,914 |
| Operating Profit | 93 | 104 | 297 | 196 | 93 | 148 | 674 | 907 | 661 | 473 | 535 | 519 | 731 |
| OPM % | 3.5% | 5% | 10% | 6% | 2.9% | 5% | 21% | 18% | 12% | 9% | 9% | 10% | 13% |
| Other Income | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 73 | 33 | 36 |
| Interest | 17 | 5 | 5 | 5 | 4 | 6 | 7 | 7 | 6 | 10 | 15 | 17 | 14 |
| Depreciation | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 68 | 91 | 101 |
| PBT | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 525 | 443 | 651 |
| Tax % | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | 26% | 26% | — |
| Net Profit | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 391 | 327 | 483 |
| EPS in Rs | 1.85 | 2.96 | 9.3 | 6.02 | 2.55 | 5.32 | 25.4 | 35.28 | 26.49 | 18.43 | 20.77 | 17.41 | 25.67 |
| Div. Payout % | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 22% | 42% | 49% | 48% | 60% | — |
Balance Sheet
| Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,194 | 2,333 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 130 | 126 |
| Other Liabilities | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 1,087 | 970 |
| Total Liabilities | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,467 |
| Fixed Assets | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 813 | 1,474 |
| CWIP | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 582 | 74 |
| Investments | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 435 | 324 |
| Other Assets | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,618 | 1,594 |
| Total Assets | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,467 |
Cash Flow
| Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 80 | 84 | 69 | 213 | 133 | 120 | 435 | 672 | 304 | 557 | 342 | 246 |
| Investing | -5 | -5 | -25 | -15 | -27 | -8 | -64 | -140 | -147 | -182 | -330 | -190 |
| Financing | -66 | -40 | -16 | -57 | -56 | -90 | -104 | -178 | -194 | -197 | -212 | -228 |
| Net Cash Flow | 9 | 39 | 27 | 141 | 50 | 22 | 266 | 354 | -37 | 178 | -201 | -171 |
| Free Cash Flow | 73 | 77 | 41 | 194 | 101 | 104 | 413 | 509 | 98 | 245 | -36 | 37 |
| CFO/OP | 96 | 117 | 53 | 140 | 167 | 107 | 89 | 99 | 72 | 140 | 87 | 67 |
Ratios
| Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 | 24 | 34 |
| Inventory Days | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 | 50 | 51 |
| Days Payable | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 | 66 | 65 |
| Cash Conversion Cycle | 1 | 3 | 19 | 0 | 3 | 0 | 4 | 8 | 14 | 0 | 8 | 20 |
| Working Capital Days | 3 | 8 | 22 | 12 | 5 | 5 | 19 | 8 | 19 | 1 | 4 | 15 |
| ROCE % | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% | 23% | 19% |
Documents
Frequently Asked Questions about Supreme Petrochem Ltd
What does Supreme Petrochem Ltd do?
Where is Supreme Petrochem Ltd (SPLPETRO) listed?
Which sector does Supreme Petrochem Ltd belong to?
What is the market capitalisation of Supreme Petrochem Ltd?
What is the PE ratio of Supreme Petrochem Ltd?
What is the 52-week high and low of Supreme Petrochem Ltd?
Does Supreme Petrochem Ltd pay dividends?
What is the Return on Equity (ROE) of Supreme Petrochem Ltd?
How can I research Supreme Petrochem Ltd on Tapetide?
Company Information
Supreme Petrochem Ltd (SPL) is a petrochemical company engaged in the business of manufacturing Polystyrene, Compounds of Styrenics and other Polymers. [1]